SBIR/STTR Research Award
ENZYME IMMOBILIZATION FOR REMOVAL OF TOXIC METABOLITES
Award amount
$398,370Program and phase
SBIR · Phase IIAward year
1990Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- SURMODICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
ENZYME DEFICIENCIES ASSOCIATED WITH INBORN METABOLIC DEFECTSARE USUALLY FATAL WITHIN THE FIRST FEW YEARS OF LIFE. TREATMENTS SUCH AS DIET MANIPULATION, GENE REPLACEMENT THERAPY, CHEMOTHERAPY, TRANSFUSIONS, TRANSPLANTATIONS, AND PERITONEAL DIALYSIS HAVE PRODUCED MARGINAL IMPROVEMENTS IN THESE PATIENTS. ENZYME REPLACEMENT THERAPY IS AN APPEALING ALTERNATIVE OR ADJUNCT TO THESE TREATMENTS. HOWEVER, DIRECT ENZYME REPLACEMENT HAS LED TO HYPERSENSITIVITY RESPONSES IN THE HOSTS, AND INSTABILITY OF SUCH PREPARATIONSHAS MADE USE OF SUCH PROCEDURES IMPRACTICAL. WE PROPOSE TO EXPLORE IMMOBILIZATION CHEMISTRIES FOR DEVELOPMENT OF ENZYME-ACTIVATED SURFACES FOR EXTRACORPOREAL REMOVAL OF TOXIC METABOLITIES. WE WILL USE PHOTOCHEMICAL PROCEDURES TOACTIVATE SUPPORT MATRICES FOR SUBSEQUENT COUPLING TO THE MODEL ENZYME, ARGINASE. SUCCESSFUL DEMONSTRATION OF THE IMPROVED ENZYME ACTIVITIES AFFORDED BY THIS TECHNOLOGY IN ANIN VITRO BLOOD SYSTEM WILL LEAD TO CONTINUATION OF THIS PROJECT WITH A CONSULTANT LABORATORY FOR PHASE II ANIMAL MODEL STUDIES.
Technology keywords
Not reported